Charlotte's Web Holdings (CWBHF) Cash & Equivalents (2020 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Cash & Equivalents of $5.2 million for Q1 2026, down 73.15% year-over-year from $19.4 million in Q1 2025, and down 35.31% quarter-over-quarter from $8.0 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Cash & Equivalents (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Cash & Equivalents for 7 consecutive years, with $5.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents fell 73.15% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (down 73.15% YoY), while the FY2025 annual figure was $8.0 million, down 64.48% from the prior year.
- Cash & Equivalents slipped to $5.2 million in Q1 2026 per CWBHF's latest filing, from $8.0 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $67.0 million in Q4 2022 and bottomed at $5.2 million in Q1 2026.
- Historically, Cash & Equivalents has averaged $30.0 million across 5 years, with a median of $22.6 million in 2024.
- Annual changes were most pronounced in 2023 — Cash & Equivalents surged 319.27% — and 2026, when it plunged 73.15%.
- Charlotte's Web Holdings' Cash & Equivalents stood at $67.0 million in 2022, then declined by 28.59% to $47.8 million in 2023, then tumbled by 52.7% to $22.6 million in 2024, then slumped by 64.48% to $8.0 million in 2025, then plunged by 35.31% to $5.2 million in 2026.
- Business Quant data shows CWBHF's Cash & Equivalents at $5.2 million in Q1 2026, $8.0 million in Q4 2025, and $9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Charlotte's Web Holdings | 63.58 Mn | 49.59 Mn | 5.16 Mn | 13.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.99 Mn |
| Mar 31, 2026 | 5.20 Mn |
| Dec 31, 2025 | 8.04 Mn |
| Sep 30, 2025 | 9.81 Mn |
| Jun 30, 2025 | 15.27 Mn |
| Mar 31, 2025 | 19.36 Mn |
| Dec 31, 2024 | 22.62 Mn |
| Sep 30, 2024 | 24.62 Mn |
| Jun 30, 2024 | 32.53 Mn |
| Mar 31, 2024 | 38.51 Mn |
| Dec 31, 2023 | 47.82 Mn |
| Sep 30, 2023 | 51.02 Mn |
| Jun 30, 2023 | 61.73 Mn |
| Mar 31, 2023 | 60.78 Mn |
| Dec 31, 2022 | 66.96 Mn |
| Sep 30, 2022 | 16.51 Mn |
| Jun 30, 2022 | 14.82 Mn |
| Mar 31, 2022 | 14.50 Mn |
| Dec 31, 2021 | 19.49 Mn |
| Dec 31, 2020 | 52.80 Mn |